IP Library Granted Patent US 10,314,501
Granted Patent B2
US 10,314,501 · App. 15/411,936 · Granted Jun 11, 2019

Implantable microstimulators and inductive charging systems

Inventors: Ralph J. Zitnik (Santa Barbara, CA); Michael A. Faltys (Valencia, CA); Jacob A. Levine (West Hempstead, NY); Jesse M. Simon (Los Angeles, CA)
Assignee: SetPoint Medical Corporation
A61B5/04001A61B5/6877A61N1/36053A61N1/3756A61N1/3787A61N1/37205A61B5/0031A61B5/7225A61B2560/0219A61B2562/12A61B2562/162A61N1/0556A61N1/3606A61N1/37229A61N1/37518
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,314,501
App. No.
15/411,936
Granted
Jun 11, 2019
Kind
B2
Abstract

Methods and apparatuses (e.g., devices and systems) for vagus nerve stimulation, including (but not limited to) sub-diaphragmatic vagus nerve stimulation. In particular, the methods and apparatuses described herein may be used to stimulate the posterior sub-diaphragmatic vagus nerve to treat inflammation and/or inflammatory disorders. The implantable microstimulators described herein may be inductively charged and/or communicated with using the external charger. The implant may include a receiving antenna wrapped around the battery and/or the housing of the microstimulator/microregulator and/or may include a high magnetic permeability material in order to serve as a magnetic core for the antenna coil. Wearable inductive chargers/communication devices for inductively communicating with (including charging) an implanted microstimulator are described herein, which may include magnetically conductive material to enhance communication with an implant, including sub-diaphragmatic implants. Also described herein are inductive chargers/communication devices, including belts, and pads (e.g., mattresses) able to recharge an implanted neurostimulation device.

Claims (25)

1. A method of treating an inflammatory disease in a patient by sub-diaphragmatic stimulation of a vagus nerve, the method comprising:

applying electrical stimulation from a leadless microstimulator coupled at least partially around a sub-diaphragmatic vagus nerve;

repeating the application of electrical stimulation of the sub-diaphragmatic vagus nerve to inhibit inflammation; and

inductively communicating with the leadless microstimulator using an inductive coil positioned adjacent to an abdominal region of the patient.

2. The method of claim 1 , wherein the leadless microstimulator comprises a batteryless microstimluator configured to apply electrical stimulation only when inductively communicating with the inductive coil.

3. The method of claim 1 , further comprising implanting the leadless microstimulator by positioning a nerve cuff over the sub-diaphragmatic vagus nerve wherein the leadless microstimulator is inserted within the nerve cuff so that two or more electrical contacts on the microstimulator are in electrical contact with the sub-diaphragmatic vagus nerve.

4. The method of claim 1 , further comprising implanting the leadless microstimulator by positioning the microstimulator within a nerve cuff in electrical contact with the sub-diaphragmatic vagus nerve.

5. The method of claim 1 , wherein the leadless microstimulator is sealed within a nerve cuff around the sub-diaphragmatic vagus nerve.

6. The method of claim 1 , wherein inductively communicating comprises inductively charging the microstimulator from a belt worn around the patient's abdominal region.

7. The method of claim 1 , wherein inductively communicating comprises inductively charging the microstimulator from a mattress on which the patient is laying.

8. The method of claim 1 , wherein applying electrical stimulation comprises applying electrical stimulation of greater than 6.5 V.

9. The method of claim 1 , wherein repeating the application of electrical stimulation comprises repeating the electrical stimulation at between every hour and every 12 hours.

10. The method of claim 1 , wherein inductively communicating comprises emitting a positional signal from the leadless microstimulator to assist in orienting the inductive coil prior to inductively communicating.

11. The method of claim 1 , wherein inductively communicating comprises receiving inductive signals using a tri-axial inductive link within the leadless microstimulator.

12. The method of claim 1 , wherein inductively communicating comprises applying a radially cycling field from outside of the patient's abdomen to communicate with the leadless microstimulator.

13. A method of treating an inflammatory disease in a patient by sub-diaphragmatic stimulation of a vagus nerve, the method comprising:

applying electrical stimulation from a leadless and batteryless microstimulator coupled at least partially around a sub-diaphragmatic vagus nerve; and

repeating the application of electrical stimulation of the sub-diaphragmatic vagus nerve to inhibit inflammation;

wherein the leadless and batteryless microstimluator applies electrical stimulation only when inductively communicating with an inductive coil positioned adjacent to an abdominal region of the patient.

14. A method of treating an inflammatory disease by sub-diaphragmatic stimulation of a vagus nerve, the method comprising:

positioning a nerve cuff over a sub-diaphragmatic vagus nerve of a patient by longitudinally introducing the nerve cuff on a posterior sub-diaphragmatic vagus nerve;

positioning a microstimulator within the nerve cuff in electrical contact with the sub-diaphragmatic vagus nerve; and

sealing the microstimulator within the nerve cuff; and

applying electrical stimulation from the microstimulator to the sub-diaphragmatic vagus nerve to inhibit inflammation; and

inductively charging the microstimulator from a belt worn around an abdominal region of the patient.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 29, 2017
From: ZITNIK, RALPH J.; FALTYS, MICHAEL A.; LEVINE, JACOB A.; SIMON, JESSE M.
To: SETPOINT MEDICAL CORPORATION
Reel/Frame 043440/0560 →
Continuity (5)
Provisional Application 62281029 · Jan 20, 2016
Provisional Application 62286940 · Jan 25, 2016
Provisional Application 62286943 · Jan 25, 2016
Provisional Application 62286945 · Jan 25, 2016
Related Publication 20170202467A1 · Jul 20, 2017
Cited By (6)
US 12,220,597 US 12,246,175 US 12,397,160 US 12,427,309 US 12,427,310 US 12,661,085